As part of the ReLive Biotechnologies Group, CO.DON is happy to see that our regenerative cell therapy product for cartilage defects will soon be available for patients in Singapore. What a great success! Since 2021, ReLive and CO.DON are collaborating closely to make this treatment option available to patients in Asia.